NGFR and amyotrophic lateral sclerosis: Both in vitro and in vivo studies have demonstrated that pharmacological inhibition of p75NTR leads to significantly reduced pathological changes in various neurological conditions such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS) [21,22,23,24,25,26,27].